Assort Health is a technology company.
Assort Health has raised $102.0M across 3 funding rounds.
Assort Health has raised $102.0M in total across 3 funding rounds.
Assort Health is a healthcare technology company that builds an omnichannel patient engagement AI platform using generative AI agents specifically designed for healthcare call centers.[1][2][3] It serves digital health providers, ambulatory practices, hospitals, health systems, health plans, life sciences, government, and pharmacies by automating tasks like appointment scheduling, cancellations, confirmations, triaging calls, prescription refills, billing inquiries, and fax processing, while integrating with over 84 EHR systems such as Epic, Cerner, athenahealth, and DrChrono.[1][3] The platform solves high call volumes, long wait times, dropped calls, and operational costs in healthcare call centers, boosting appointment revenue, labor capacity by 48%, and patient satisfaction up to 94% through training on 1.2 million edge cases and 55 million patient interactions.[1][3] With rapid growth, Assort Health has raised $102 million in total funding ($29.5 million across early rounds and $76 million in a Series B as of mid-2025), employs about 16 people, and is trusted by thousands of providers.[2][4]
Assort Health was founded in 2023 by Jonathan (Jon) Wang and Jeffery (Jeff) Liu, both with expertise in healthcare technology, and is headquartered in San Francisco, California.[2] The idea emerged from recognizing inefficiencies in healthcare call centers, where manual handling leads to delays and lost revenue; the founders developed conversational AI to automate and augment these operations, starting with specialty-specific voice agents for areas like orthopedics, cardiology, and immunology.[2][4] Early traction came quickly through initial product development funded by a Series A round, enabling market entry and real-world case studies showing reduced dropped calls and increased appointment volumes, followed by a $76 million Series B to fuel expansion.[1][2][4]
Assort Health rides the wave of agentic AI in healthcare, where autonomous AI agents handle complex, conversational workflows amid surging demand for efficient patient access post-pandemic.[1][3][4] Timing is ideal as healthcare faces staffing shortages, rising call volumes, and EHR interoperability mandates, amplified by generative AI advancements enabling natural language processing for nuanced patient interactions.[1][2] Market forces like value-based care and telehealth growth favor Assort, reducing no-shows and boosting engagement while competitors like Actium Health or Avaamo offer broader or less specialized tools.[1] It influences the ecosystem by setting standards for specialty-specific AI, improving provider efficiency, and enabling scalable patient navigation for thousands of organizations.[2][3]
Assort Health's momentum positions it to dominate healthcare voice AI, with Series B funds accelerating specialty expansions and global reach amid AI's shift toward multi-modal, omnichannel agents.[2][4] Trends like deeper EHR-AI fusion, regulatory pushes for AI safety (e.g., HIPAA evolutions), and personalized medicine will shape its path, potentially tripling provider adoption as labor crunches intensify.[1][3] Its influence may evolve from call center automation to full patient journey orchestration, solidifying its role as the go-to for accessible, high-quality care navigation and redefining how thousands of providers scale operations.[3]
Assort Health has raised $102.0M in total across 3 funding rounds.
Assort Health's investors include Kevin Hartz, Andreessen Horowitz, Creandum, FasterCapital, First Round Capital, ICONIQ Capital, Lead Edge Capital, Lightspeed Venture Partners, Quiet Capital, Sequoia Capital, Susa Ventures, Cristina Cordova.
Assort Health has raised $102.0M across 3 funding rounds. Most recently, it raised $76.0M Series B in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $76.0M Series B | Kevin Hartz, Andreessen Horowitz, Creandum, FasterCapital, First Round Capital, ICONIQ Capital, Lead Edge Capital, Lightspeed Venture Partners, Quiet Capital, Sequoia Capital, Susa Ventures, Cristina Cordova, Gordon Wintrob, Scott Belsky, Zack Kanter | |
| Apr 1, 2025 | $22.0M Series A | Kevin Hartz, Andreessen Horowitz, Creandum, FasterCapital, First Round Capital, ICONIQ Capital, Lead Edge Capital, Lightspeed Venture Partners, Quiet Capital, Sequoia Capital, Susa Ventures, Cristina Cordova, Gordon Wintrob, Scott Belsky, Zack Kanter | |
| Mar 1, 2024 | $4.0M Seed | Andreessen Horowitz, First Round Capital, Lightspeed Venture Partners, Quiet Capital |